Breaking barriers in cancer treatment: Race Oncology pioneers a new era with bisantrene
Race Oncology (ASX:RAC) has announced positive results in killing cancer cells in combination with the drug bisantrene
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
TON | Re-Elect FRAZER & COSTELLO | 13/05/24 | 26 | 7.4K | |||
|
|||||||
TON Graphite | Daily trading and Chart | 05/05/24 | 70 | 27K | |||
|
|||||||
TON | Ann: Quarterly Activities/Appendix 5B Cash Flow Report | 30/04/24 | 6 | 2.1K | |||
|
|||||||
TON | Ann: Corporate Governance Statement | 30/04/24 | 33 | 13K | |||
|
|||||||
TON | Ann: Notice of Annual General Meeting/Proxy Form | 17/04/24 | 2 | 1.2K | |||
|
|||||||
TON | Ann: Appendix 4G | 28/03/24 | 0 | 215 | |||
|
|||||||
TON | Ann: Annual Report to shareholders | 28/03/24 | 0 | 493 | |||
|
|||||||
TON | Ann: Listing rule 3.13.1 | 27/03/24 | 0 | 401 | |||
|
See All Discussions
Timeline
|
|||||
|
|||||
|
|||||
|
|||||
|
|||||
|
|||||
View More |